This is a preprint.
Bidirectional relationship between olfaction and Parkinson's disease
- PMID: 37905151
- PMCID: PMC10615003
- DOI: 10.1101/2023.10.18.23297218
Bidirectional relationship between olfaction and Parkinson's disease
Update in
-
Bidirectional relationship between olfaction and Parkinson's disease.NPJ Parkinsons Dis. 2024 Dec 5;10(1):232. doi: 10.1038/s41531-024-00838-4. NPJ Parkinsons Dis. 2024. PMID: 39639040 Free PMC article.
Abstract
Background: Hyposmia (loss of smell) is a common early symptom of Parkinson's disease (PD). The shared genetic architecture between hyposmia and PD is unknown.
Methods: We leveraged genome-wide association study (GWAS) results for self-assessment of 'ability to smell' and PD diagnosis. Linkage disequilibrium score regression (LDSC) and Local Analysis of [co]Variant Association (LAVA) were used to identify genome-wide and local genetic correlations. Mendelian randomization was used to identify potential causal relationships.
Results: LDSC found that sense of smell negatively correlated at a genome-wide level with PD. LAVA found negative correlations in four genetic loci near GBA1, ANAPC4, SNCA, and MAPT. Using Mendelian randomization we found evidence for strong causal relationship between PD and liability towards poorer sense of smell, but weaker evidence for the reverse direction.
Conclusions: Hyposmia and PD share genetic liability in only a subset of the major PD risk genes. While there was definitive evidence that PD can lower the sense of smell, there was only suggestive evidence for the reverse. This work highlights the heritability of olfactory function and its relationship with PD heritability and provides further insight into the association between PD and hyposmia.
Keywords: Mendelian randomization; Parkinson’s disease; genetics; hyposmia; loss of smell.
Conflict of interest statement
Sara Bandres Ciga: grants from National Institute on Aging (ZIAAG000534, 1ZIAAG000534) Alastair Noyce: grants from Parkinson’s UK, Barts Charity, Cure Parkinson’s, NIHR, Innovate UK, Virginia Keiley benefaction, Alchemab, Aligning Science Across Parkinson’s Global Parkinson’s Genetics Program (ASAP-GP2) and Michael J Fox Foundation. Karl Heilbron: former employee of 23andMe Inc. and holds stock and stock options in 23andMe, Inc. Cornelis Blauwendraat: grants from National Institute of Aging (ZIAAG000534, 1ZIAAG000534), National Institute of Neurological Disorders and Stroke (ZO1 AG000535, ZIA AG000949)
Figures


References
-
- Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s Disease: Variation by Age, Gender, and Race/Ethnicity. Am J Epidemiol. 2003;157:1015–22. - PubMed
-
- Rees RN, Noyce AJ, Schrag A. The prodromes of Parkinson’s disease. Eur J Neurosci [Internet]. 2019. [cited 2023 May 14];49. Available from: https://pubmed.ncbi.nlm.nih.gov/30447019/ - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources